Cargando…

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Detalles Bibliográficos
Autores principales: Wu, Huan, Li, Rongrong, Zhang, Zhiwei, Jiang, Huiyang, Ma, Hanlin, Yuan, Cunzhong, Sun, Chenggong, Li, Yingwei, Kong, Beihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071567/
https://www.ncbi.nlm.nih.gov/pubmed/32169110
http://dx.doi.org/10.1186/s13048-020-00628-5
_version_ 1783506230954688512
author Wu, Huan
Li, Rongrong
Zhang, Zhiwei
Jiang, Huiyang
Ma, Hanlin
Yuan, Cunzhong
Sun, Chenggong
Li, Yingwei
Kong, Beihua
author_facet Wu, Huan
Li, Rongrong
Zhang, Zhiwei
Jiang, Huiyang
Ma, Hanlin
Yuan, Cunzhong
Sun, Chenggong
Li, Yingwei
Kong, Beihua
author_sort Wu, Huan
collection PubMed
description
format Online
Article
Text
id pubmed-7071567
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70715672020-03-18 Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer Wu, Huan Li, Rongrong Zhang, Zhiwei Jiang, Huiyang Ma, Hanlin Yuan, Cunzhong Sun, Chenggong Li, Yingwei Kong, Beihua J Ovarian Res Correction BioMed Central 2020-03-13 /pmc/articles/PMC7071567/ /pubmed/32169110 http://dx.doi.org/10.1186/s13048-020-00628-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Wu, Huan
Li, Rongrong
Zhang, Zhiwei
Jiang, Huiyang
Ma, Hanlin
Yuan, Cunzhong
Sun, Chenggong
Li, Yingwei
Kong, Beihua
Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
title Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
title_full Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
title_fullStr Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
title_full_unstemmed Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
title_short Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
title_sort correction to: kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071567/
https://www.ncbi.nlm.nih.gov/pubmed/32169110
http://dx.doi.org/10.1186/s13048-020-00628-5
work_keys_str_mv AT wuhuan correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT lirongrong correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT zhangzhiwei correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT jianghuiyang correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT mahanlin correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT yuancunzhong correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT sunchenggong correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT liyingwei correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer
AT kongbeihua correctiontokallistatininhibitstumourprogressionandplatinumresistanceinhighgradeserousovariancancer